Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study

Purpose The aim of this study is to assess international guidelines implementation concerning thromboprophylaxis strategy in myeloma patients treated with immunomodulatory drugs. Methods This retrospective study includes multiple myeloma patients treated with immunomodulatory drugs between 2014 and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2022-04, Vol.148 (4), p.975-984
Hauptverfasser:	Leclerc, V., Karlin, L., Herledan, C., Marchal, L., Baudouin, A., Gouraud, A., Caffin, A. G., Larbre, V., Lazareth, A., Bachy, E., Salles, G., Ghesquières, H., Rioufol, C., Ranchon, F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic drugs Antiplatelet therapy Antitumor agents Cancer Research Drugs Hematology Immunomodulation Immunomodulators Internal Medicine Medicine Medicine & Public Health Multiple myeloma Oncology Original Article – Clinical Oncology Patients Thalidomide Thromboembolism Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!